Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?

by Talbot, Kevin
Published 2014

Mimics and chameleons in motor neurone disease

by Turner, Martin R, Talbot, Kevin
Published 2013

Swallowing and oropharyngeal dysphagia

by Turner, Martin R, Talbot, Kevin
Published in Clin Med (Lond) (2014)

Sweet food preference in amyotrophic lateral sclerosis

by Turner, Martin R, Talbot, Kevin
Published in Pract Neurol (2017)

Pathogenesis of FUS-associated ALS and FTD: insights from rodent models

by Nolan, Matthew, Talbot, Kevin, Ansorge, Olaf
Published in Acta Neuropathol Commun (2016)

The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS

by Dafinca, Ruxandra, Barbagallo, Paola, Talbot, Kevin
Published in Front Cell Neurosci (2021)

Advances in motor neurone disease

by Bäumer, Dirk, Talbot, Kevin, Turner, Martin R
Published 2014

GARS axonopathy: not every neuron's cup of tRNA

by Motley, William W., Talbot, Kevin, Fischbeck, Kenneth H.
Published 2010

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy

by Sleigh, James N., Gillingwater, Thomas H., Talbot, Kevin
Published 2011

Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease

by Herrando-Grabulosa, Mireia, Casas, Caty, Talbot, Kevin, Aguilera, José
Published in Toxins (Basel) (2020)

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis

by Turner, Martin R, Goldacre, Raph, Talbot, Kevin, Goldacre, Michael J
Published in J Neurol Neurosurg Psychiatry (2016)

Psychiatric disorders prior to amyotrophic lateral sclerosis

by Turner, Martin R., Goldacre, Raph, Talbot, Kevin, Goldacre, Michael J.
Published in Ann Neurol (2016)

Towards a TDP-43-Based Biomarker for ALS and FTLD

by Feneberg, Emily, Gray, Elizabeth, Ansorge, Olaf, Talbot, Kevin, Turner, Martin R.
Published in Mol Neurobiol (2018)

A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3

by Chen, Zhefan Stephen, Huang, Xiaoying, Talbot, Kevin, Chan, Ho Yin Edwin
Published in Cell Death Dis (2021)

Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study

by Turner, Martin R., Goldacre, Raph, Ramagopalan, Sreeram, Talbot, Kevin, Goldacre, Michael J.
Published 2013

The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset

by Proudfoot, Malcolm, Jones, Ashley, Talbot, Kevin, Al-Chalabi, Ammar, Turner, Martin R.
Published in Amyotroph Lateral Scler Frontotemporal Degener (2016)

Amyotrophic lateral sclerosis: the complex path to precision medicine

by Talbot, Kevin, Feneberg, Emily, Scaber, Jakub, Thompson, Alexander G., Turner, Martin R.
Published in J Neurol (2018)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly

by PEREIRA, ERLICK A. C., TURNER, MARTIN R., WASS, JOHN A. H., TALBOT, KEVIN
Published 2010

Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis

by Fabes, Jeremy, Matthews, Lucy, Filippini, Nicola, Talbot, Kevin, Jenkinson, Mark, Turner, Martin R.
Published in Acad Radiol (2017)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy

by Turner, Bradley J, Bäumer, Dirk, Parkinson, Nicholas J, Scaber, Jakub, Ansorge, Olaf, Talbot, Kevin
Published 2008